Jillian Cooper

Dr. Jillian Cooper is committed to innovative research in cancer molecular biology, with a particular focus on acute myeloid leukemia (AML). As a Clinical Assistant Professor of Medicine at Thomas Jefferson University, she is dedicated to advancing our understanding of cancer cytogenetics and the molecular underpinnings of AML. Dr. Cooper earned her MD from Sidney Kimmel Medical College and completed her residency at Thomas Jefferson University, where she further honed her expertise in the field of medicine. In addition to her medical degree, Dr. Cooper completed a fellowship in Point of Care Ultrasound at Thomas Jefferson University, which has equipped her with a unique skill set that enhances her clinical practice and research endeavors. Her work is characterized by a meticulous approach to unraveling the complex genetic and molecular landscapes of cancer, with the ultimate goal of improving patient outcomes. Dr. Cooper's research is driven by a passion for uncovering the clinical, cytogenetic, and molecular findings in AML, aiming to contribute to the development of more effective diagnostic and therapeutic strategies. Her commitment to the field is reflected in her numerous publications and presentations at national and international conferences. Beyond her research, Dr. Cooper is deeply committed to fostering an environment of inclusion and respect within the medical community. She believes that diversity and collaboration are key to driving innovation and excellence in medical research and education. Her dedication to mentorship and teaching is evident in her interactions with students and colleagues, where she encourages open dialogue and the exchange of ideas. Dr. Cooper's contributions to the field of cancer research and her commitment to medical education make her a valuable asset to Thomas Jefferson University and the broader medical community. Her work continues to inspire and pave the way for future advancements in the understanding and treatment of cancer.